These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16222948)

  • 1. Complications and comorbidities of type 2 diabetes.
    Norris AW; Svoren BM
    Pediatr Ann; 2005 Sep; 34(9):710-8. PubMed ID: 16222948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglycemia Is the Main Mediator of Prediabetes- and Type 2 Diabetes-Associated Impairment of Microvascular Function: The Maastricht Study.
    Sörensen BM; Houben AJHM; Berendschot TTJM; Schouten JSAG; Kroon AA; van der Kallen CJH; Henry RMA; Koster A; Reesink KD; Dagnelie PC; Schaper NC; Schalkwijk CG; Schram MT; Stehouwer CDA
    Diabetes Care; 2017 Aug; 40(8):e103-e105. PubMed ID: 28626010
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrovascular Complications in Patients with Diabetes and Prediabetes.
    Huang D; Refaat M; Mohammedi K; Jayyousi A; Al Suwaidi J; Abi Khalil C
    Biomed Res Int; 2017; 2017():7839101. PubMed ID: 29238721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent lipid abnormalities in diabetes; are we approaching the treatment optimally?
    Hitman GA
    Diabet Med; 2011 Nov; 28(11):1281. PubMed ID: 22004300
    [No Abstract]   [Full Text] [Related]  

  • 5. Early microvascular complications of prediabetes in mice with impaired glucose tolerance and dyslipidemia.
    Schaefer C; Biermann T; Schroeder M; Fuhrhop I; Niemeier A; Rüther W; Algenstaedt P; Hansen-Algenstaedt N
    Acta Diabetol; 2010 Dec; 47 Suppl 1():19-27. PubMed ID: 19367364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities and microvascular complications of type 2 diabetes in children and adolescents.
    Dean HJ; Sellers EA
    Pediatr Diabetes; 2007 Dec; 8 Suppl 9():35-41. PubMed ID: 17991131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From hyperglycemia to the risk of cardiovascular disease.
    Leiter LA
    Rev Cardiovasc Med; 2006; 7 Suppl 2():S3-9. PubMed ID: 17224875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of cardiovascular and renal complications in older adults with normal or impaired glucose tolerance or NIDDM. A population-based study.
    Wingard DL; Barrett-Connor EL; Scheidt-Nave C; McPhillips JB
    Diabetes Care; 1993 Jul; 16(7):1022-5. PubMed ID: 8359095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Combinations of Glucose Tolerance and Blood Pressure Status and Incident Diabetes, Hypertension, and Chronic Kidney Disease.
    Derakhshan A; Bagherzadeh-Khiabani F; Arshi B; Ramezankhani A; Azizi F; Hadaegh F
    J Am Heart Assoc; 2016 Aug; 5(8):. PubMed ID: 27543801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health risks and interventions in prediabetes: A review.
    Mahat RK; Singh N; Arora M; Rathore V
    Diabetes Metab Syndr; 2019; 13(4):2803-2811. PubMed ID: 31405710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological aspects of prediabetes--review of the current data.
    Zargar AH; Bashir MI
    J Indian Med Assoc; 2005 Nov; 103(11):591-3. PubMed ID: 16570761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National surveillance for type 1, type 2 diabetes and prediabetes among children and adolescents: a population-based study (SAUDI-DM).
    Al-Rubeaan K
    J Epidemiol Community Health; 2015 Nov; 69(11):1045-51. PubMed ID: 26085648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature.
    Nalysnyk L; Hernandez-Medina M; Krishnarajah G
    Diabetes Obes Metab; 2010 Apr; 12(4):288-98. PubMed ID: 20380649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Introduction: Symposium on diabetes, inflammation and cardiovascular disease.
    Smith U
    J Intern Med; 2007 Aug; 262(2):142-4. PubMed ID: 17645582
    [No Abstract]   [Full Text] [Related]  

  • 15. Type 2 Diabetes in Canadian Aboriginal Adolescents: Risk Factors and Prevalence.
    Spurr S; Bally J; Bullin C; Trinder K
    J Pediatr Nurs; 2017; 36():111-117. PubMed ID: 28888490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-prandial hyperglycaemia and vascular disease.
    Hanefeld M
    Int J Clin Pract Suppl; 2000 Sep; (112):13-8. PubMed ID: 11064946
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-prandial hyperglycemia and microvascular complications.
    Dhanwal D; Tandon N
    J Assoc Physicians India; 2001 Jan; 49 Spec No():28-31. PubMed ID: 11235602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A
    Lakartidningen; 2001 Feb; 98(9):937-40. PubMed ID: 11292972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health burden in type 2 diabetes and prediabetes in The Maastricht Study.
    Veugen MGJ; Onete VG; Henry RMA; Brunner-La Rocca HP; Koster A; Dagnelie PC; Schaper NC; Sep SJS; van der Kallen CJH; van Boxtel MPJ; Reesink KD; Schouten JS; Savelberg HHCM; Köhler S; Verhey FR; van den Bergh JPW; Schram MT; Stehouwer CDA
    Sci Rep; 2022 May; 12(1):7337. PubMed ID: 35513556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future risk of diabetes in mother and child after gestational diabetes mellitus.
    Damm P
    Int J Gynaecol Obstet; 2009 Mar; 104 Suppl 1():S25-6. PubMed ID: 19150058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.